Eltrombopag Added to Standard Immunosuppressive Treatment as Front‐Line Therapy for Severe Aplastic Anemia: Long‐Term Outcomes of the Phase‐3 Randomized Superiority EBMT ‐ SAAWP RACE Study

Study limitation reported by the research below: “The brand name 'Revolade' (EU) is used; the US brand name is 'Promacta'. Both refer to eltrombopag.”